Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 361 AL 375

Tau protein in Alzheimer’s disease

Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):607. doi: 10.2174/156720511796717159.

Berberine: a potential multipotent natural product to combat Alzheimer's disease

Ji HF, Shen L.

Molecules. 2011 Aug 9;16(8):6732-40. doi: 10.3390/molecules16086732.

Age correction in dementia--matching to a healthy brain

Dukart J, Schroeter ML, Mueller K; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2011;6(7):e22193. doi: 10.1371/journal.pone.0022193. Epub 2011 Jul 29.

Brain aging in the graying population: not all the same color

Au R.

Neurology. 2011 Aug 23;77(8):706-7. doi: 10.1212/WNL.0b013e31822b013a. Epub 2011 Aug 10.

Intracellular trafficking of the β-secretase and processing of amyloid precursor protein

Chia PZ, Gleeson PA.

IUBMB Life. 2011 Sep;63(9):721-9. doi: 10.1002/iub.512. Epub 2011 Aug 10.

Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease

Cho JE, Kim JR.

Recent Pat CNS Drug Discov. 2011 Sep 1;6(3):222-33. doi: 10.2174/157488911796958002.

Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain

Sarkar P, Narayanan J, Harder DR.

Neuroscience. 2011 Oct 27;194:241-9. doi: 10.1016/j.neuroscience.2011.07.058. Epub 2011 Jul 30.

Insoluble cellular prion protein and its association with prion and Alzheimer diseases

Zou WQ, Zhou X, Yuan J, Xiao X.

Prion. 2011 Jul-Sep;5(3):172-8. doi: 10.4161/pri.5.3.16894. Epub 2011 Jul 1.

Small heat shock proteins induce a cerebral inflammatory reaction

Bruinsma IB, de Jager M, Carrano A, Versleijen AA, Veerhuis R, Boelens W, Rozemuller AJ, de Waal RM, Verbeek MM.

J Neurosci. 2011 Aug 17;31(33):11992-2000. doi: 10.1523/JNEUROSCI.0945-11.2011.

A pilot usability study of MINWii, a music therapy game for demented patients

Boulay M, Benveniste S, Boespflug S, Jouvelot P, Rigaud AS.

Technol Health Care. 2011;19(4):233-46. doi: 10.3233/THC-2011-0628.

New drugs for Alzheimer's disease in Japan

Takeda M, Tanaka T, Okochi M.

Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x.

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran E, Mercken M, De Strooper B.

Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. doi: 10.1038/nrd3505.

Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease

Hunter JM, Bowers WJ, Maarouf CL, Mastrangelo MA, Daugs ID, Kokjohn TA, Kalback WM, Luehrs DC, Valla J, Beach TG, Roher AE.

J Alzheimers Dis. 2011;27(2):361-76. doi: 10.3233/JAD-2011-110608.

CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases

Williamson R, van Aalten L, Mann DM, Platt B, Plattner F, Bedford L, Mayer J, Howlett D, Usardi A, Sutherland C, Cole AR.

J Alzheimers Dis. 2011;27(3):615-25. doi: 10.3233/JAD-2011-110617.

[Neuroprotective role of silent information regulator 1 in Alzheimer's disease]

Yang XR, Wang R, Qin HP, Zhao X, Liu NH, Zhang C.

Sheng Li Xue Bao. 2011 Aug 25;63(4):396-400.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias